Analysts have estimated the hemp-CBD market to hit 22 billion by 2022, as consumers around the world increasingly looking to CBD oils, edibles, and other products to help treat chronic pain conditions and as a potential preventative measure for muscle soreness and inflammation.
American’s positive attitude toward the legalization of cannabis could be beneficial for publicly traded companies in the Cannabis/CBD space such as Peoplesway.com, Inc. (OTC: PLWY), CV Sciences Inc (OTC: CVSI) and Potnetwork Holdings, Inc. (OTC: POTN)
Peoplesway.com, Inc. (OTC: PLWY), Peoplesway is a publicly traded corporation headquartered in Charlotte, North Carolina. The company has a rich family heritage in direct sales, dating back 35 years when they began marketing the finest quality skincare through multilevel marketing. The company helped to create several millionaires and it surpassed $500 million in worldwide sales before its founders retired a decade ago. Today, Peoplesway is building on its strong heritage – even selling one of the original products from that skincare line. Led by a management team with more than 100 years of combined experience, the company has a new focus and a broad vision for the future. Peoplesway has set its sights on becoming a leader in the wellness revolution, helping people to achieve financial independence and an unprecedented level of health and vitality.
PLWY is now entering the CBD market with Topical CBD Creams, CBD OIL, CBD Gummies, and CBD Infused Water Beverages.
CV Sciences, Inc. (OTC: CVSI) operates as a life science company. It operates through two segments, Specialty Pharmaceuticals and Consumer Products. The company focuses on developing and commercializing prescription drugs utilizing synthetic cannabidiol (CBD) as the active pharmaceutical ingredient. Its initial drug candidate is CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company also engages in the development, manufacture, marketing, and sale of consumer products containing plant-based CBD under the PlusCBD Oil name in various market sectors, including nutraceutical, beauty care, specialty foods, and vape.
The company recently announced its certification by the US Hemp Authority™ Guidance Program.
This achievement illustrates the Company’s robust quality management system throughout its supply chain from seed to shelf. This certification is a milestone indicative of the Company’s commitment to assuring that customers continue to receive the highest quality products from CV Sciences and that all PlusCBD Oil™ products are safe. Additionally, this certification should give law enforcement officials certainty that the company’s products are not made from genetic strains of marijuana.
Last month, Diamond CBD Inc.,wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC: POTN) announced that it is presenting its popular line of Diamond CBD oils, edibles, and creams to several large pharmacy chains.
“Our array of CBD products already play an active role in the wellness routine of thousands of Americans,” said Kevin Hagen, CEO of Diamond CBD parent company PotNetwork Holdings, Inc. “That’s why we are happy to present the benefits of CBD and our popular oils, edibles and beauty products to several large pharmacy chains in the days ahead.”